Journal of Biological Chemistry · 2000 · 199 citations · 35 references
Life SciencesBiochemistryMolecular BiologyGene ExpressionRna ProcessingTranscriptionRna CleavageTranscription In EukaryotesAntisense Oligonucleotide-directed CleavageAntisense RnasDouble-stranded Rna CleavagePre-messenger Rna 3' End ProcessingPre-mrna CleavageRibonuclease Iii CleavageRibosomal Rnas
A human RNase III gene encodes a protein of 160 kDa with multiple domains, a proline-rich, a serine- and arginine-rich, and an RNase III domain. The expressed purified RNase III domain cleaves double-strand RNA and does not cleave single-strand RNA. The gene is ubiquitously expressed in human tissues and cell lines, and the protein is localized in the nucleus of the cell. The levels of transcription and translation of the protein do not change during different phases of the cell cycle. However, a significant fraction of the protein in the nucleus is translocated to the nucleolus during the S phase of the cell cycle. That this human RNase III is involved in processing of pre-rRNA, but might cleave at sites different from those described for yeast RNase III, is shown by antisense inhibition of RNase III expression. Inhibition of human RNase III expression causes cell death, suggesting an essential role for human RNase III in the cell. The antisense inhibition technique used in this study provides an effective method for functional analysis of newly identified human genes. A human RNase III gene encodes a protein of 160 kDa with multiple domains, a proline-rich, a serine- and arginine-rich, and an RNase III domain. The expressed purified RNase III domain cleaves double-strand RNA and does not cleave single-strand RNA. The gene is ubiquitously expressed in human tissues and cell lines, and the protein is localized in the nucleus of the cell. The levels of transcription and translation of the protein do not change during different phases of the cell cycle. However, a significant fraction of the protein in the nucleus is translocated to the nucleolus during the S phase of the cell cycle. That this human RNase III is involved in processing of pre-rRNA, but might cleave at sites different from those described for yeast RNase III, is shown by antisense inhibition of RNase III expression. Inhibition of human RNase III expression causes cell death, suggesting an essential role for human RNase III in the cell. The antisense inhibition technique used in this study provides an effective method for functional analysis of newly identified human genes. double-strand RNA ribonuclease III ribosomal RNA rapid amplification of cDNA ends Dulbecco's phosphate-buffered saline fluorescence-activated cell sorter serine and arginine external transcribed spacer internal transcribed spacer kilobase(s) glutathioneS-transferase RNase III enzymes are highly conserved double-strand RNA (dsRNA)1 endoribonucleases expressed in most, perhaps all, living cells (1Robertson H.D. Methods Enzymol. 1990; 181: 189-202Crossref PubMed Scopus (19) Google Scholar, 2Court D. Belasco J. Brawerman G. Control of Messenger RNA Stability. Academic Press, Inc., New York1993: 71-116Crossref Google Scholar). The COOH-terminal portion of the enzyme contains a dsRNA-binding domain, which has been found exclusively in proteins recognizing dsRNA. NMR methods have suggested that the dsRNA-binding domain has an α-β-β-β-α topology in which a three-stranded anti-parallel β-sheet packs on one side against the two α-helices (3Kharrat A. Macias M.J. Gibson T.J. Nilges M. Pastore A. EMBO J. 1995; 14: 3572-3584Crossref PubMed Scopus (246) Google Scholar). The enzyme also contains a catalytic domain independent from substrate-binding domain, which implies that substrate recognition is not necessarily coupled to catalysis. All RNase III species cloned to date contain a signature sequence (HNERLEFLGDS). In some species like Drosophila andCaenorhabditis elegans the enzyme contains 2 copies of the sequence (4Filippov V. Solovyev V. Filippova M. Gill S.S. Gene ( Amst. ). 2000; 245: 213-221Crossref PubMed Scopus (113) Google Scholar) which may suggest that some RNase IIIs may be capable of forming an active catalytic center as monomers. Deletion and mutation of this sequence abolishes the catalytic activity of the enzyme (5Nashimoto H. Uchida H. Mol. Gen. Genet. 1985; 201: 25-29Crossref PubMed Scopus (49) Google Scholar, 6Nicholson A.W. Prog. Nucleic Acids Res. Mol. Biol. 1996; 52: 1-65Crossref PubMed Google Scholar). In Escherichia coli, RNase III forms a homodimer (7Dunn J.J. J. Biol. Chem. 1976; 251: 3807-3814Abstract Full Text PDF PubMed Google Scholar) and requires a divalent metal ion. The enzyme produces 5′-phosphate, 3′-hydroxy termini and participates in RNA maturation and decay pathways by site specifically cleaving double-helical structures in cellular and viral RNAs. By comparing RNase III substrates, Zhang and Nicholson (8Zhang K. Nicholson A.W. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 13437-13441Crossref PubMed Scopus (89) Google Scholar) showed several specific Watson-Crick base pairs at defined positions relative to the cleavage site. Introducing these disfavored base pairs into a model substrate inhibited efficient cleavage in vitro by interfering with RNase III binding. By comparing sequences of a large number of S. cerevisiae RNase III substrates and introducing mutations in the model substrate, Chanfreau et al. (9Chanfreau G. Buckle M. Jacquier A. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 3142-3147Crossref PubMed Scopus (78) Google Scholar) suggested that yeast RNase III cleavage specificity may be based on recognizing consensus AGNN tetraloops and cleaving the substrate at a fixed distance from the tatraloop. Multiple functions have been ascribed to RNase III. In E. coli RNase III has been reported to affect the expression of several phage, plasmid, and cellular genes (6Nicholson A.W. Prog. Nucleic Acids Res. Mol. Biol. 1996; 52: 1-65Crossref PubMed Google Scholar, 10Arraiano C.M. World J. Microbiol. Biotechnol. 1993; 9: 421-432Crossref PubMed Scopus (7) Google Scholar). The E. coli enzyme participates in the rRNA maturation process by processing 16 S and 23 S from the primary 30 S precursor (6Nicholson A.W. Prog. Nucleic Acids Res. Mol. Biol. 1996; 52: 1-65Crossref PubMed Google Scholar). RNase III also plays a determinant role in control of the decay of messenger RNA and thus the level of corresponding proteins (2Court D. Belasco J. Brawerman G. Control of Messenger RNA Stability. Academic Press, Inc., New York1993: 71-116Crossref Google Scholar, 11Santos J.M. Drider D. Marujo P.E. Lopez P. Arraiano C.M. FEMS Microbiol. Lett. 1997; 157: 31-38Crossref PubMed Google Scholar). In yeast, it has been suggested that RNase III is a general factor in small nuclear RNA processing since enzyme cleavage sites were identified in several small nuclear RNA species (U1, U2, and U5). As these RNAs are essential components of the mRNA splicing apparatus (12Chanfreau G. Elela S.A. Ares Jr., M. Guthrie C. Genes Dev. 1997; 11: 2741-2751Crossref PubMed Scopus (98) Google Scholar, 13Abou Elela S. Ares Jr., M. EMBO J. 1998; 17: 3738-3746Crossref PubMed Scopus (104) Google Scholar, 14Seipelt R.L. Zheng B. Asuru A. Rymond B.C. Nucleic Acids Res. 1999; 27: 587-595Crossref PubMed Scopus (66) Google Scholar, 15Ares Jr., M. Weiser B. Prog. Nucleic Acids Res. Mol. Biol. 1995; 50: 131-159Crossref PubMed Scopus (79) Google Scholar, 16Madhani H.D. Guthrie C. Annu. Rev. Genet. 1994; 28: 1-26Crossref PubMed Scopus (319) Google Scholar, 17Staley J.P. Guthrie C. Cell. 1998; 92: 315-326Abstract Full Text Full Text PDF PubMed Scopus (914) Google Scholar), RNase III is thought to play a role in pre-mRNA processing. Yeast RNase III (RNT1) is also required for the synthesis of several small nucleolar RNAs from large precursors (18Chanfreau G. Rotondo G. Legrain P. Jacquier A. EMBO J. 1998; 17: 3726-3737Crossref PubMed Scopus (140) Google Scholar, 19Qu L.H. Henras A. Lu Y.J. Zhou H. Zhou W.X. Zhu Y.Q. Zhao J. Henry Y. Caizergues-Ferrer M. Bachellerie J.P. Mol. Cell. Biol. 1999; 19: 1144-1158Crossref PubMed Scopus (139) Google Scholar, 20Chanfreau G. Legrain P. Jacquier A. J. Mol. Biol. 1998; 284: 975-988Crossref PubMed Scopus (141) Google Scholar). As most small nucleolar RNAs are implicated in site-specific cleavage of precursor ribosomal RNA (20Chanfreau G. Legrain P. Jacquier A. J. Mol. Biol. 1998; 284: 975-988Crossref PubMed Scopus (141) Google Scholar, 21Tollervey D. Science. 1996; 273: 1056-1057Crossref PubMed Scopus (64) Google Scholar, 22Tollervey D. Kiss T. Curr. Opin. Cell Biol. 1997; 9: 337-342Crossref PubMed Scopus (380) Google Scholar), the yeast enzyme is thought to play a key role in ribosome biogenesis (23Elela S.A. Igel H. Ares Jr., M. Cell. 1996; 85: 115-124Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar, 24Kufel J. Dichtl B. Tollervey D. RNA. 1999; 5: 909-917Crossref PubMed Scopus (125) Google Scholar). Additionally, RNase III mutants of E. coli accumulate unprocessed pre-rRNA but are still viable because an alternative pathway for the processing of 16 S rRNA exists, and 23 S rRNA retaining unprocessed extensions at its 5′ and 3′ ends can assemble into functional ribosomes (25Gegenheimer P. Watson N. Apirion D. J. Biol. Chem. 1977; 252: 3064-3073Abstract Full Text PDF PubMed Google Scholar). On the other hand, the yeast RNase III (RNT1) is an essential gene in Saccharomyces cerevisiae. To date, human RNase III has not been cloned. We now report the cloning and characterization of a cDNA that expresses a human RNase III. We demonstrate that the human enzyme is distinctly different from the homologues in other species and is involved in pre-rRNA processing. An internet search of the XREF data base in the National Center of a human expressed to yeast RNase III number and its C. elegans RNase III number The of and corresponding to the human expressed sequence sequence By 3′ amplification of 3′ the human RNase III cDNA 3′ from the expressed sequence by human cDNA as and the and the as The and its The The The were to in the in and to a for by were as a in at for with and at for The were from the and purified by into a and to A human cDNA the as specific The cDNA were into from and to of the with an by the cDNA from the of the were not to the of human RNase III several of based on the from the cloned cDNA were these several of 5′ were to which in of cDNA A and The sequences were and by the of and analysis were by the A search on the data base the An domain and an RNase III domain were purified and to with and used to in and were purified with and III coupled to E. D. A Scholar). and from cells were as described Nucleic Acids Res. 11: PubMed Scopus Google Scholar). and nuclear were in the were by were used to the protein The proteins were to a and for purified at The were the method and A cDNA the human RNase domain by and into a site site into the sites of the expression to the RNase III protein with glutathioneS-transferase at its The of the by The III protein expressed in E. coli and purified with protein Control protein also in from the The purified were identified by and with III The substrate by of two of RNA with and transcription of the of the The with and purified with and The were transcribed RNA with The transcribed RNAs were purified by on and were and for at in a and RNase were to the were and The at for 2 and the RNA purified on The also used as the control To of protein III of purified protein were with and at in a yeast and RNase in the of The were at specific and and cells were in for were with and fixed in for by with cells were for 30 with were with for at with and for at with the Inc., The cells were with and in for a cells were at phase the method P. The Cell A Press, New York1993: Scholar). cells were in Dulbecco's and 2 for with cells were in Dulbecco's for by a for cells were with and at and for and cells were from with and with were fixed in for at by for at Cell and were by analysis and were and purified as described H. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). were cells were with with Inc., at for at in Dulbecco's the cells were in Dulbecco's for to and for mRNA sites and of antisense to to human RNase III in sequences are All the the is the of and with a of RNase III mRNA level by antisense with for to control not control and not in sequences are All the the is the of and with a of RNase III mRNA level by antisense with for to control not control and not RNA from different human cell the method K. in Inc., New Scholar). of RNA on a and to by The multiple were also from To RNase III by human RNase III cDNA in at for 2 were in a of at for 30 To pre-rRNA and by to and to S rRNA at for 2 and in 2 at for were The cloning is described in and and in the to based on a search of the XREF data an cDNA corresponding to the COOH-terminal portion of the protein cloned by 3′ were by a cDNA with this The two and to the COOH-terminal and base of the and based on the portion of the 5′ to a cDNA of which encodes the of the In the a cDNA of the portion cloned. to the several were but of these The most is which the sequence base the 5′ with the and based on and the portion of the cDNA were and to a human RNase III cDNA with the of number The cDNA a sequence of to that encodes a The of the protein is 160 kDa based on the of the as the translation site. The is in with the translation consensus sequence M. J. Cell Biol. PubMed Scopus Google Scholar). 3′ portion of that the human RNase III mRNA ubiquitously expressed in human tissues and cell portion of used to were not with C. yeast, and RNase III, the of human RNase III is and contains multiple The RNase III domain is at the of the protein and is conserved with other species as C. yeast, and RNase III. domain with C. elegans RNase III the human RNase III domain and C. elegans RNase III contain two RNase III signature The human RNase III domain also contains multiple The human protein also contains and the The and RNase III are by the analysis of expression of human RNase III. a of RNA of human cell were with human RNase III COOH-terminal cDNA the with a cDNA a 2 of RNA from human tissues with cDNA the with cDNA To the human RNase III domain can specifically cleave the RNase III into a glutathioneS-transferase expression The III protein and were purified and by of the and analysis with RNase III not showed that the human RNase III domain However, of during expression and with and the III protein the significant cleavage of substrate the cleavage not to with from E. and and A were used as to that the cleavage cleavage not As described and of III domain with of dsRNA. the RNase III domain perhaps active the reported activity for yeast RNase III (23Elela S.A. Igel H. Ares Jr., M. Cell. 1996; 85: 115-124Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar). However, the and and the substrate have not been and the RNase III domain has been is required with the human enzyme of the specific of the enzymes are To the expression of the human RNase III two were The from a corresponding to the RNase III domain in the COOH-terminal portion of the The from a corresponding to the domain of the protein these were to the and of human RNase III. The a in cell with a of 160 kDa which is the protein that the is expressed in The III also a protein in cells and that protein with the protein identified with the domain not were different human cell and with not To that the protein is expressed in human the protein purified with an RNase III domain The purified protein on by not To the of the nuclear and from cells and other human cell not were and of proteins were by RNase III in the nuclear of to the during The to those with the not To the of human RNase III, the protein identified in cells by The of cells were by not and that human RNase III is in the also that RNase III is localized in nucleus and in used to cells to phase P. The Cell A Press, New York1993: Scholar). to the cells S to cells the were significant in the mRNA protein levels of the RNase III during phases not However, the of the protein during the cell cycle. the cells were with and in S RNase III protein in the nucleus and not the and from RNase III translocated to a at cells were in S phase that RNase III in the and The protein in the for and from as cells phase and of RNase III in the by with an not of of to from the nucleolus in these To the of human RNase III, antisense inhibition of expression of the protein To sites in RNase III mRNA for antisense antisense to sites in the mRNA were and for inhibition of RNase III antisense as substrates for RNase to RNA in of the RNA and have been shown to be highly specific used the in study H. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). that significant in the of the antisense as a of the site to which were to in the RNase III The most effective to a site in the of the for Multiple control were and the from on a control with a base and to the antisense are of of RNase III with in of of the RNase III mRNA A and The on the that by the may be a mRNA of RNase III The control at on the RNase III mRNA at RNase III mRNA levels in cells from 2 to a some data not with at for RNase III protein to of The level of RNase III protein at and a at showed that with RNase III in the nucleus and of inhibition of RNase III on pre-rRNA processing. of human S pre-rRNA and processing of cells with and for and levels of RNase III mRNA and and S pre-rRNA in cells with at RNase III. shown are of of are not the is the of cells with at for the of cells from to of of the cells from the and be with cell The cells that to the substrate of the cells with at suggest that RNase III is required for cell The control at on cell RNase III mRNA protein levels the antisense highly that has been to RNase III in species is pre-rRNA processing (23Elela S.A. Igel H. Ares Jr., M. Cell. 1996; 85: 115-124Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar, Cell. 19: Full Text PDF PubMed Scopus Google Scholar). As the human protein to be translocated to and from the nucleolus during the cell its in human pre-rRNA processing. for human pre-rRNA were to to the 5′ external transcribed spacer of human pre-rRNA C. D. J. Mol. Biol. 1990; PubMed Scopus Google Scholar) and to to S rRNA H. 1976; PubMed Scopus Google Scholar). that cellular RNA from cells by to a and a corresponding to S pre-rRNA and a corresponding in to 30 S pre-rRNA were corresponding to S and S pre-rRNA and S rRNA were at which the antisense the RNase III on the S pre-rRNA level and In the that antisense inhibition of RNase III the levels of S and S The study that with at and S to accumulate at and to at provides that RNase III is involved in pre-rRNA processing. In this the of antisense to to different sites in RNase III mRNA on RNase III mRNA levels to the of these on of the two pre-rRNA species that with the most of the antisense As has been different sites in RNAs are to antisense as the of antisense to to different sites in RNase III mRNA The the of RNase III RNA levels and the of S and S In this cloned a cDNA a human RNase III enzyme which is its yeast (5Nashimoto H. Uchida H. Mol. Gen. Genet. 1985; 201: 25-29Crossref PubMed Scopus (49) Google Scholar, S.A. Igel H. Ares Jr., M. Cell. 1996; 85: 115-124Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar, N. Apirion D. Proc. Natl. Acad. Sci. U. S. A. 1985; PubMed Scopus Google Scholar, P.E. J. M. Nucleic Acids Res. 1985; PubMed Scopus Google Scholar, M. M. Nucleic Acids Res. 1990; PubMed Scopus Google Scholar, Y. A. M. EMBO J. PubMed Scopus Google Scholar, J. 1997; PubMed Google Scholar). the as the translation the encodes a protein with a of 160 The of that human RNase III may in that its and that it may be The and are in proteins that play in mRNA splicing RNA. 1995; Google Scholar). The of and RNase III into a protein that human RNase III may be involved in a number of RNA The of multiple sites that the enzyme may be by The of the protein in nucleus and in pre-mRNA and pre-rRNA processing. coli, RNase III is with ribosomes in the H.D. J. Biol. Chem. Full Text PDF PubMed Google Scholar). The reported are the to demonstrate that a RNase III is localized in the In human phases of and as a of the cell cycle. and during the and of to during and during the phase M. J. Cell Sci. 1977; Google Scholar). RNase III translocated to and in the during S phase suggesting that RNase III may have specific functions in during S The that might nucleolar are but of and other may be In the of this protein provides an to human RNA processing. To the of human RNase III, inhibition of expression of the protein with antisense The levels of S and S were the RNase III suggesting that the protein plays a role in pre-rRNA processing. two pathways for processing human pre-rRNA M. S. Bachellerie J.P. J. 1993; PubMed Scopus Google Scholar). In one human pre-rRNA processing is thought to cleavage of S pre-rRNA into 30 S and S The S RNA of the cleavage of S pre-rRNA contains S and S cleavage in S pre-rRNA and S rRNA The S pre-rRNA is to S Inhibition of RNase III in of S pre-rRNA, of S pre-rRNA and of S is that this human RNase III is required for the cleavage in processing of S it to be required for the processing of S may also be involved in the processing of S pre-rRNA, but the that the of S pre-rRNA is to the inhibition of processing of S the site of cleavage by human RNase III in these is in the of is distinctly different from the cleavage sites reported for yeast RNase III (RNT1) (23Elela S.A. Igel H. Ares Jr., M. Cell. 1996; 85: 115-124Abstract Full Text Full Text PDF PubMed Scopus (192) Google Scholar). of RNase III in of the primary pre-rRNA in cleavage sites have been to the and of yeast this human RNase III to be involved in cleavage at a different site in pre-rRNA and a different in the processing of pre-rRNA relative to However, in are required to in cleavage may other of the human RNase III involved in different in the processing of methods of cellular of this RNase III that in cleavage sites and the to in other in the processing of pre-rRNA may be Additionally, this enzyme might have other as involved in processing mRNA (2Court D. Belasco J. Brawerman G. Control of Messenger RNA Stability. Academic Press, Inc., New York1993: 71-116Crossref Google Scholar) small nuclear RNAs and small nucleolar RNAs (12Chanfreau G. Elela S.A. Ares Jr., M. Guthrie C. Genes Dev. 1997; 11: 2741-2751Crossref PubMed Scopus (98) Google Scholar, 13Abou Elela S. Ares Jr., M. EMBO J. 1998; 17: 3738-3746Crossref PubMed Scopus (104) Google Scholar, 14Seipelt R.L. Zheng B. Asuru A. Rymond B.C. Nucleic Acids Res. 1999; 27: 587-595Crossref PubMed Scopus (66) Google Scholar, G. Rotondo G. Legrain P. Jacquier A. EMBO J. 1998; 17: 3726-3737Crossref PubMed Scopus (140) Google L.H. Henras A. Lu Y.J. Zhou H. Zhou W.X. Zhu Y.Q. Zhao J. Henry Y. Caizergues-Ferrer M. Bachellerie J.P. Mol. Cell. Biol. 1999; 19: 1144-1158Crossref PubMed Scopus (139) Google Scholar). data showed that RNase III expression inhibited by antisense the level of a mRNA A. H. T. T. K. J. PubMed Google Scholar). A also that of a of RNase III mRNA suggesting that RNase III may be involved in mRNA inhibition of RNase III may in the to RNase III RNA cleavage by RNase III. with for of the cells were and In cells levels of RNase III might be to a of RNase III protein in these cells which might be in different phases of cell the RNAs were also from it is that the on S and S were shown in and showed that RNase III protein the antisense In cell and at the suggesting that the of the may have been do not the that human RNase III might have other functions that might be for cell RNase III mRNA to that the of RNase III protein may be to an to the cell and from the that it is that this may be and suggest that the protein may be to is required to these these a for the functional analysis of newly genes. a of antisense is and for of mRNA of of the mRNA and protein are The specificity of can be by of its on several and specific be A of the gene can be by analysis of antisense of mRNA and protein levels to by a of different of the of the different with in the is that the is to the gene can be used to essential genes and functions in is technique in significant to and the to for the gene during In antisense inhibition of the mRNA causes a and inhibition of transcription of the gene and thus provides of the of the gene in the of a We and for and for during the
35
Antibodies, a laboratory manual
Biomedicine & Pharmacotherapy · 1989 · 12.5K citations
The superfamily of arginine/serine-rich splicing factors.
Xiang‐Dong Fu · PubMed · 1995 · 675 citations
Structure of the dsRNA binding domain of E. coli RNase III.
A. Kharrat, María J. Macias, Toby J. Gibson et al. · The EMBO Journal · 1995 · 278 citations · Full text